In 2010, the researchers implemented a structured monthly conference review confirming whether each patient complication warranted an adverse event report and whether physicians reported these events in a timely manner. The research team then retrospectively analyzed the conference minutes over the next five years.
The study included 46,660 patient encounters, 1,160 (2.5 percent) major and minor complications, and 462 (1.0 percent) reportable adverse events.
The percentage of adverse events reported increased from 67 percent to 98 percent from 2011 to 2015. The researchers found the number of months from the start of the conference review was a significant predictor of the likelihood of adverse event reporting.
“Increasing [adverse event] reporting occurred after initiation of a [monthly conference compliance review],” the researchers concluded.
More articles on clinical leadership and infection control:
Current screening tools may not be effective at diagnosing maternal sepsis
Detroit hospital cited after insects found in ICU
2nd pediatric flu death reported in 2018-19 season
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
